Key facts
- This page summarizes Ofir Koren's Form 3 filing for Nano-X Imaging Ltd. (NNOX).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 11:28.
Ofir Koren - 18 Mar 2026 Form 3 Insider Report for Nano-X Imaging Ltd. (NNOX)
- Reporting relationship
- General Manager, ARC Division
- Issuer ticker
- NNOX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Marina Gofman Feler, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ofir Koren filed Form 3 for Nano-X Imaging Ltd. (NNOX) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001661277
Primary reporting owner
Koren Ofir
- Relationship
- General Manager, ARC Division
- Address
- C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
- Signature
- /s/ Marina Gofman Feler, attorney-in-fact
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NNOX
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 18 Mar 2026
- Ownership
- Direct
NNOX
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
NNOX
holding
Ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 39,474
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 100,000
- Exercise price
- $49.68
- Footnotes
- F3
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 25,000
- Exercise price
- $17.63
- Footnotes
- F4
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 33,500
- Exercise price
- $11.52
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The ordinary shares reported in this row consist of the remaining unsold shares underlying 20,000 restricted share units ("RSUs") that were granted to the Reporting Person on April 16, 2024 and that vest in 16 equal quarterly installments of 6.25% each (1,250 RSUs) on each three-month anniversary of the grant date, such that all RSUs reported in this row will be exercisable by the four-year anniversary of the grant date (April 16, 2028).
Footnote F2
The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on February 5, 2026, of which 50% vest on the 12-month anniversary of the grant date and the remaining 50% vest on the 24-month anniversary of the grant date.
Footnote F3
The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
Footnote F4
4. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (March 28, 2026).
Footnote F5
5. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
SEC remarks
Exhibit 24.1 Power of Attorney